your partner in preclinical research


Patient Derived tumor Xenografts (PDX), a new approach of preclinical oncology.

Patient Derived tumor Xenografts (PDX)

PDX development is perfomed in partnership with our affliate Urolead.

PDX is a new approach of preclinical oncology. PDX model considers the heterogeneity of patient tumors in all its aspects (genetic, histology, molecular…).

PDX models are developed by direct transfer of surgically resected patient tumor tissue into immune-compromised mice. Xenograft tissues can be cryopreserved and thawed for drug evaluation studies.


Patient Derived tumor Xenografts


urosphere and pdx development


+ Clinical anonymized information of patient tumor


+ PDX establishment and characterization




Visite Urolead Website